A photo of Thomas Korfhagen.

Tom R. Korfhagen, MD, PhD


  • Attending Physician, Perinatal Institute, Neonatology and Pulmonary Biology
  • Professor, UC Department of Pediatrics
I recognize the potential of every baby to grow and progress developmentally. I support parents and help them realize the incredible possibilities in every baby, regardless of any medical concerns.

About

Biography

I work as a pediatrician for newborn babies discharged from the neonatal intensive care unit (NICU) at Cincinnati Children's and other regional hospitals. I also provide care to newborns in regional hospitals covered by the Perinatal Institute.

As an attending doctor for the Perinatal Institute and the Division of Neonatology and Pulmonary Biology, I care for babies with complex needs in person and through telemedicine visits. I like people to know my name and encourage them to call me Tom.

I recognize the potential of every baby to grow and progress developmentally. I support parents and help them realize the incredible possibilities in every baby, regardless of any medical concerns.

My work with families is inspired by Jeffrey A. Whitsett, MD, co-director of the Perinatal Institute. I was part of the team, led by Dr. Whitsett, on research to develop a pulmonary surfactant for newborns with neonatal respiratory distress. Thanks to these studies, surfactant is now the standard of care for babies with severe neonatal respiratory distress.

Our research also looks at lung injury problems and understanding how pathological changes, such as alveolar simplification and fibrosis, occur. Knowing what happens in these processes is key to learning more about bronchopulmonary dysplasia, the most common chronic lung disease affecting preterm babies.

Other ongoing research centers on identifying molecular targets that can be changed to improve the health of babies with bronchopulmonary dysplasia.

When I’m not working, I spend time with my grandkids. I enjoy seeing them grow and learn, and I support the activities that they enjoy. There is nothing better than happy, smiling children.

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease. Sontake, V; Kasam, RK; Sinner, D; Korfhagen, TR; Reddy, GB; White, ES; Jegga, AG; Madala, SK. JCI insight. 2018; 3.

Endothelial immune activation programmes cell-fate decisions and angiogenesis by inducing angiogenesis regulator DLL4 through TLR4-ERK-FOXC2 signalling. Xia, S; Menden, HL; Korfhagen, TR; Kume, T; Sampath, V. Journal of Physiology. 2018; 596:1397-1417.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey